\
&
Contact us
\
&
Contact us
Published on | 1 month ago
Programmes RIThe aim of these cascading grants is to enhance the activities of RDA Working Groups through the adoption and further development of Working Group outputs. With a focus on outputs that lead to impact on the Open Science landscape, the cascading grants will ultimately contribute to the interoperability of Open Science solutions within the European Open Science Cloud (EOSC).
The cascading grants call is open not just to RDA Working Groups seeking to facilitate the adoption of their outputs, but also to organisations outside the RDA (for instance, research institutes or private companies) who wish to adopt an RDA output or recommendation. Any entity eligible to receive Horizon Europe funding can apply, barring consortium members of the RDA TIGER project.
The total budget made available with this cascade grants call is €50,000 and it is expected to award between 3 and 5 grants with a funding range between €10,000 – €16,666, depending on applications received.
The deadline for applications is 27 April 2025. The selected projects are expected to be launched in May 2025 and need to be concluded by the end of October 2025.
All information related to the call is available on this section of the RDA Alliance website.
The RDA TIGER project
RDA TIGER is an abbreviation of Research Data Alliance facilitation of Targeted International working Groups for EOSC-related Research solutions. It is a two-year project funded under the Horizon Europe Research Infrastructures work programme, more specifically the destination Enabling an operational, open and fair EOSC ecosystem (INFRAEOSC).
The project supports RDA Working Groups that concretely align, harmonise, and standardise Open Science developments and technologies globally. The services it provides will facilitate and support coherent and consistent working group definitions and increase the impact of the key European initiatives on the global level.
The project will directly contribute to the EOSC Partnership by supporting (via the Working Groups) the international engagement and alignment of policies, technologies, methodologies, practices and other outputs of EOSC-related and other European Open Science developments. More information about the RDA TIGER project can be found here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Climate, Energy, Mobility Agro-Food, Environment
The Clean Industrial Deal is described as "a bold business plan to support the competitiveness and resilience of our industry." It aims to boost production in green industries, with special focus on energy-intensive industries - vital for European material production and decarbonization goals. 6 main elements The Deal presents measures to boost e... read more
Security Digital, Industry & Space Digital Europe
In Digital Europe, knowledge of the underlying EU policies and legislations is a key element when drafting a proposal, as they play an important role in the “relevance” evaluation criterion. Also for Horizon Europe Cluster 3 (Cybersecurity) and Cluster 4 (Digital), this knowledge can be handy for applicants. To support... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
